160 related articles for article (PubMed ID: 9367082)
1. Thyroid carcinoma.
Gillenwater AM; Weber RS
Cancer Treat Res; 1997; 90():149-69. PubMed ID: 9367082
[TBL] [Abstract][Full Text] [Related]
2. [From the cytogenetics to the cytogenomics of thyroid tumors].
Perissel B; Bernheim A; Couturier J; Fouilhoux G; Vago P
Bull Cancer; 2002 Jun; 89(6):588-92. PubMed ID: 12135859
[TBL] [Abstract][Full Text] [Related]
3. [Medullary thyroid carcinoma and other rare types of thyroid carcinoma].
Obara T
Nihon Rinsho; 2007 Nov; 65(11):2087-91. PubMed ID: 18018575
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of thyroid tumors and surgical decision-making.
Learoyd DL; Messina M; Zedenius J; Robinson BG
World J Surg; 2000 Aug; 24(8):923-33. PubMed ID: 10865036
[TBL] [Abstract][Full Text] [Related]
5. RAS proto-oncogene in medullary thyroid carcinoma.
Moura MM; Cavaco BM; Leite V
Endocr Relat Cancer; 2015 Oct; 22(5):R235-52. PubMed ID: 26285815
[TBL] [Abstract][Full Text] [Related]
6. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
[TBL] [Abstract][Full Text] [Related]
7. Management of microcarcinomas (papillary and medullary) of the thyroid.
Wu LS; Milan SA
Curr Opin Oncol; 2013 Jan; 25(1):27-32. PubMed ID: 23042124
[TBL] [Abstract][Full Text] [Related]
8. Management of medullary thyroid cancer.
Ball DW
Minerva Endocrinol; 2011 Mar; 36(1):87-98. PubMed ID: 21460789
[TBL] [Abstract][Full Text] [Related]
9. [Cellular oncogenes and antioncogenes in thyroid tumors].
Abrosimov AIu
Arkh Patol; 1997; 59(1):64-9. PubMed ID: 9139613
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic aspects in medullary thyroid carcinoma.
Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N
Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676
[TBL] [Abstract][Full Text] [Related]
11. [Medullary thyroid cancer - the present state of art].
Krysiak R; Marek B; Okopień B
Endokrynol Pol; 2008; 59(5):446-55. PubMed ID: 18979455
[TBL] [Abstract][Full Text] [Related]
12. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
Albarel F; Conte-Devolx B; Oliver C
Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
[TBL] [Abstract][Full Text] [Related]
13. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
14. [Differentiated thyroid cancer -- 2009].
Konrády A
Orv Hetil; 2011 Jan; 152(5):163-70. PubMed ID: 21247857
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma: recent advances and management update.
Marsh DJ; Learoyd DL; Robinson BG
Thyroid; 1995 Oct; 5(5):407-24. PubMed ID: 8563482
[TBL] [Abstract][Full Text] [Related]
16. Medullary thyroid carcinoma and biomarkers: past, present and future.
van Veelen W; de Groot JW; Acton DS; Hofstra RM; Höppener JW; Links TP; Lips CJ
J Intern Med; 2009 Jul; 266(1):126-40. PubMed ID: 19522831
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic dysregulation in thyroid neoplasia.
Kondo T; Asa SL; Ezzat S
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
[TBL] [Abstract][Full Text] [Related]
18. An overview of molecular abnormalities leading to thyroid carcinogenesis: a 1993 perspective.
Gagel RF
Stem Cells; 1997; 15 Suppl 2():7-13. PubMed ID: 9368282
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in treatment of medullary thyroid carcinoma.
Vezzosi D; Bennet A; Caron P
Ann Endocrinol (Paris); 2007 Jun; 68(2-3):147-53. PubMed ID: 17391636
[TBL] [Abstract][Full Text] [Related]
20. Management of hereditary medullary thyroid carcinoma.
Pappa T; Alevizaki M
Endocrine; 2016 Jul; 53(1):7-17. PubMed ID: 26839093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]